drugset / Trial / NCT00247273
A Study of Monthly Risedronate for Osteoporosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to study the efficacy of a single-dose monthly dosing regimen as compared to the standard daily dosing regimen of risedronate 5 mg daily.
Timeline
- Start
- 2005-10
- Primary completion
- 2008-03
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risedronate | Small molecule | 5 mg | Oral |
| Subject | Risedronate | Small molecule | 150 mg | Oral |